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[57] ABSTRACT 
The disclosed invention concerns improving the meta 
bolic stability of newborn pigs and increasing their 
survival rate by administering to a pregnant sow during 
its late stages of gestation an effective amount of a mate 
rial selected from the group consisting of a dihydroxy 
alkanol having 3 to 10 carbon atoms, a triglyceride of 
glycerol and fatty acids containing 8 to 12 carbon atoms 
and the mono-and diol esters of said alkanols and said 
fatty acids. 
6 Claims, N0 Drawings 
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METHOD FOR IMPROVING THE METABOLIC 
STABILITY AND SURVIVAL OF NEWBORN PIGS 
BACKGROUND AND SUMMARY OF THE 
INVENTION ‘ 
The present invention relates to an improved method 
for increasing the survival rate of baby pigs. More par 
ticularly, the present invention is directed to a method 
of increasing the survival rate of baby pigs by using a 
food supplement in the diet of a pregnant pig. 
The low survival rate observed in baby pigs, e. g., 20 
to 30% mortality between birth and weaning, is attrib 
uted largely to two factors: 
(1) the high degree of metabolic immaturity in the 
newborn pig and 
(2) an insufficient energy intake by the pig in its ?rst 
2 or 3 days of life. 
The magnitude of this loss can be emphasized by the 
fact that 'each 1% improvement in pig survival will 
generate an additional $4.00 to $7.00 pro?t per litter. 
The major metabolic defects observed in the new 
born pig are summarized as follows: . 
1'. A low level of phosphorylase potentially decreases 
the rate of production of glucose from glycogen stores; 
2. A defective gluconeogenic capacity limits the sup 
ply of glucose available to animals exposed to stress; 
3. A de?cient hepatic mitochondria number limits the 
use of carbohydrates as well as fatty acids for energy 
production; 
4. A small amount of body fat impairs both thermoin 
sulation and the quantitative contribution of fat as a 
major energy source; and ' 
5. A defective amino metabolismv tends to limit a 
source of substrate (carbon skeletons) for gluconeogen 
esis. 
More speci?cally, the high mortality rate observed in 
pigs is attributed largely to the newborn pigs impaired 
thermostability and defective gluconeogenic capacity 
and its inability to obtain a suf?cient energy intake from 
the sow’s milk during its ?rst 2 or 3 days of life. Because 
of these major metabolic defects, as well as the others 
set forth hereinabove, particularly. its low gluconeo 
genic capacity, the neonatal pig rapidly develops hypo 
glycemia after birth if not permitted to suckle or if 
subject to cold stress. ' 
This rapid onset of hypoglycemia in the newborn pig 
is the result of 95% of the pig’s energy reserves in the 
form of glycogen being used within the ?rst 72 hours of 
birth regardless of whether the pig is suckled or not by 
the sow. The signi?cance of the baby pig’s susceptibility 
to hypoglycemia is indicated by the 30 to 50% death 
loss observed within 72 hours after birth when baby 
pigs are fasted from birth or when baby pigs are fed for 
6 hours after birth and then fasted. 
Research has been conducted to identify factors 
which would reduce baby pig mortaility. These investi 
gations have suggested that the existence of physiolog 
ical conditions, i.e., diabetes, starvation, high dietary fat 
intake, etc., which are associated with elevated blood 
ketone levels in the sow, may result in heavier, more 
metabolically stable pigs at birth. 
Accordingly, an object of the present invention is to 
provide an improved method for increasing the survival 
rate of baby pigs. 
A further object of the present invention is to provide 
a method for improving the metabolic stability of the 
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newborn pig by preventing the development of hypo 
glycemia in the neonatal pig shortly after birth. 
Still another object of the present invention is to 
provide a food supplement which is effective in elevat 
ing the ketone levels in blood of the pregnant pig. 
Other subjects and further scope of applicability of 
the present invention is to provide a food supplement 
which is effective in elevating the ketone levels in blood 
of the pregnant pig. 
Other objects and further scope of applicability of the 
present invention will become apparent from the de 
tailed description given hereinafter. However, it should 
be understood that the detailed description and speci?c 
examples, While indicating preferred embodiments of 
the invention, are given by way of illustration only, 
since various changes and modi?cations within the 
spirit and scope of the invention will become apparent 
to those skilled in the art from this detailed description. 
Pursuant to the present invention, it has been found 
that the administration of speci?c alcohols and glycer 
ides to female pigs during late stages of gestation effec 
tively increases the liver glycogen stores in the pig at 
birth and prolongs the availability of the liver glycogen 
stores in the newborn pig. This increased availability of 
glycogen delays the onset of hypoglycemia in the pig 
and increases the survival rate (percent of pigs born 
alive that survive to weaning) of neonatal pigs. 
The alcohols which can be used according to the 
present invention include dihydroxy alkanols having 3 
to 10 carbon atoms and the mono- and diesters of such 
diols and fatty acids containing 8—12 carbon atoms, such 
as for example, 1,3-butanediol monooctanoate. The 
preferred alkanol is 1,3-butanediol. 
The glycerides which can be used in the present in 
vention include the medium chain length triglycerides 
such as for example the reaction product of glycerol 
and fatty acids containing 8 to 12 carbon atoms. 
The alkanols and the glycerides are administered to 
the pregnant pig as a food supplement, for example, as 
an addition to a corn-soybean meal diet. The alkanol 
supplement, for example, 1,3-Butanediol, which is a 
ketone former, has been found to be palatable and ef? 
ciently utilized by the pig when included as a food 
supplement to provide about .6 to 20% of the dietary 
energy in the pigs diet as shown in the following table: 
TABLE 2 
1,3-Butanediol Supplementation in Growing Swine. 
1,3-Butanediol, % of dietary energy 
Trait 0 8 17 25 33 42 
Wt. gain, kg 19.5 20.5 21.4 11.9 4.3 1.1 
ME intake, Mcal 197 212 219 157 85 77 
ME/wt gain, Meal/kg ' 10.1 10.3 10.2 13.2 19.8 70.0 
Plasma 
B-hydroxybutyrate, 159 415 457 425 831 980 
nmole/ml 
Acetoacetate, nmole/ml 69 100 115 183 150 198 
Glucose, mg/dl 75 72 95 97 142 119 
As can be seen from the table, higher dietary levels of 
1,3-Butanediol, e.g., greater than 25% of the dietary 
energy, tend to depress feed consumption and subse 
quent growth. 
Because ketones have shown to be readily transferred 
across the placenta, 1,3-Butanediol, a ketone former, 
represents a potential ‘supplemental’ energy source for 
the developing fetus. 
4,329,359 
3 
According to the present invention, it has been found 
that a short-term administration of 1,3-Butanediol in 
sows during late gestation results in an increased liver 
glycogen content in the newborn pig and an improved 
pig survival from birth to weaning. Advantageously, 
the administration of the speci?c food additive of the 
present invention can begin about 4 to 12 days, advanta 
geously about 9 days, before parturition and continue 
until parturition. After parturition, the sows are ‘allowed 
to consume a standard lactation diet. 
The following example is provided as being exem 
plary of the present invention and should not be consid 
ered as being limitative of the present invention. 
EXAMPLE 
Sixty-eight sows were fed isocaloric intakes (6000 
kcal of metabolizable energy/sow/day) of a forti?ed 
corn-soybean meal diet plus an additional 1600 kcal of 
metabolizable energy in the form of starch or 1,3 
Butanediol beginning approximately 8 days before par 
turition. After parturition, all sows were allowed to 
consume a standard lactation diet ad libitum. The results 
are shown in the following table: ~ 
TABLE 3 
1,3-Butanediol Supplementation in Sows During Late Gestation.” 
Prepartum Treatment“ 
Trait Control 1,3-butanediol Change 
Pigs/ litter 
At birth 10.39 10.14 
At weaning 8.79 9.28 +.49 
_ Avg. Pig Wt. (kg) 
At birth 1.20 1.26 +06 
At weaning 3.51 3.58 +.08 
Pig Survival, % 85.30 92.00 +6.7 
Liver Glycogen, % 11.10 16.20 +5.1 
“Thirty-eight and 40 litters represented in the control and 1,3-butanediol treatments, 
respectively. 
As can be seen from the above table, the 1,3 
Butanediol supplementation did not influence the num 
ber of live pigs born/litter (10.14 vs 10.39) or the aver 
age pig weights (g) at birth (1,259 vs 1,205) or at wean 
ing (3575 vs 3510) compared to those of litters from 
sows fed starch. However, 1,3-Butanediol supplementa 
tion did increase liver glycogen levels in the newborn 
pig (16.2 vs 11.1%) and did increase the total number of 
pigs weaned/litter (9.28 vs 8.79) and the percent of pigs 
born alive (92.0 vs 85.3) that survived to weaning com 
pared to those of the starch treatment group. Sow feed 
intake and weight gain during lactation were not af 
fected by dietary treatment. 
In a second experiment, the addition of 1,3 
Butanediol to the diet of sows during late gestation was 
shown to increase the metabolic stability of the new 
born pig by increasing the level of liver glycogen pres 
ent in the pig at birth and delaying the onset of hypogly 
cemia in pigs which were allowed to nurse or were 
fasted from birth to 12 hr of age (table 4). In addition, 
the colostrum of sows fed 1,3-Butanediol contained a 
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higher percent fat than that of sows fed the control diet 
(table 5). 
TABLE 4 
Effect on 1,3-Butanediol Supplementation in Sows During Late 
Gestation on Plasma Glucose and Liver Glycogen Stores 
in Neonatal Pigs.” 
Age of Feeding Prepartum Treatment” 
Pig, hr Regime Control 1,3-Butanediol 
Liver glycogen, mg 
0 — 3.47 4.30 
12 Nursed .70 .85 
12 Fasted .48 - .96 
Blood glucose, mg/dl 
o _ 137.6 122.7 
12 Nursed 92.7 124.2 
12 Fasted 84.7 93.8 
"Thirty and 42 pigs represented in the control and 1,3-Butanediol treatments, 
respectively. 
TABLE 5 
Effect of 1,3-Butanediol Supplementation in Sows During Late 
' Gestation on the Fat and Protein Content of Sow’s Colostrum.“ 
Prepartum Treatment“ 
Hr Postpartum Control 1,3-Butanediol 
Colostrum fat, % 
0 2.7 4.3 
12 3.1 3.9 
Colostrum protein, % 
O 13.8 15.1 
12 10.5 10.5 
"Ten and fourteen sows represented in the control and 1,3-Butanediol treatments, 
respectively. 
What is claimed: 
1. A method of treating a pregnant sow to improve 
the metabolic stability of newborn pigs and to increase 
the survival rate of said newborn pigs which comprise 
administering to the pregnant sow during its late stages 
of gestation an effective amount of a material selected 
from the group consisting of a dihydroxy alkanol hav 
ing' 3 to 10 carbon atoms, a triglyceride of glycerol and 
fatty acids containing 8 to 12 carbon atoms and the 
mono- and diol esters of said alkanols and said fatty 
acids. ' 
2. The method of claim 1 wherein the dihydroxy 
alkanol is 1,3-butanediol. 
3. The method of claim 1 wherein the alkanol, the 
triglyceride or the diol ester of said alkanols and fatty 
acids are added as a food supplement to the sow’s diet. 
4. The method of claim 3 wherein the alkanol, the 
triglyceride or the diol ester of said alkanols and fatty 
acids are added in an amount sufficient to provide about 
6 to 20% of the dietary energy in the sow’s diet. 
5. The method of claim 1 wherein the alkanol, the 
triglyceride and the diol esters of said alkanols and fatty 
acids are administered about 4 to 12 days before parturi 
tion and continued until parturition. 
6. The method of claim 1 wherein the diester is 1,3 
butanediol monooctanoate. 
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